MétaCan
Menu
Back to cohort
Record W4415203048 · doi:10.1016/j.prenap.2025.100402

‘Functional mushrooms saved my daughter’s Life’: A preliminary mixed methods survey study of Reishi (Ganoderma lucidum) and lion’s mane (Hericium erinaceus) for epilepsy

2025· article· en· W4415203048 on OpenAlexaff
Matthew X. Lowe, Quinn A. Darby, Hugo R. Seguin, Todd Boylan, Evan Lewis, Sarah-Kate Boylan, Sasha Kalcheff-Korn, Heather Jackson

Bibliographic record

VenuePharmacological Research - Natural Products · 2025
Typearticle
Languageen
FieldChemistry
TopicChemical synthesis and alkaloids
Canadian institutionsHospital for Sick ChildrenSickKids FoundationNorth York General HospitalUniversity of Toronto
Fundersnot available
KeywordsEpilepsyQuality of life (healthcare)Thematic analysisCognitionClinical trialQualitative researchHealth related quality of life

Abstract

fetched live from OpenAlex

A significant proportion of epilepsy patients are resistant to conventional treatments. Functional mushrooms such as Reishi ( Ganoderma lucidum ) and Lion’s Mane ( Hericium erinaceus ) have recognized health benefits, including neuroprotective and anti-seizure effects. This mixed-methods study investigates the use of these mushrooms as adjunctive therapies for epilepsy among 19 participants, including caregivers on behalf of a minor. The majority (n = 14) met criteria for drug-resistant epilepsy (DRE). Participants completed surveys and structured interviews addressing functional mushroom use, quality of life (QoL), sleep quality, health outcomes, seizure activity, and caregiver burden. Qualitative data underwent thematic content analysis. Compared with the general population, participants utilizing functional mushrooms noted comparable scores in physical health, psychological health, social relationships, and environmental health. Self-report responses indicated improvements in seizure control, including reduced seizure frequency and severity, cognitive and developmental outcomes, and overall quality of life since starting use of functional mushrooms. Caregivers emphasized both benefits and ongoing challenges in managing epilepsy. Functional mushrooms are a sustainable and widely available resource, and the findings presented here suggest they could complement existing treatments for epilepsy, particularly in DRE, though further clinical trials are needed to establish efficacy, optimize dosing, and clarify mechanisms of action. • Functional mushrooms (Reishi and Lion’s Mane) were associated with reduced seizure severity and frequency in individuals with epilepsy, including drug-resistant cases. • Participants reported improvements in quality of life, cognitive functioning, and developmental outcomes, aligning with both quantitative and qualitative findings. • Caregivers noted reduced stress and burden when seizure severity decreased, pointing to broader family benefits. • A subset of participants with drug-resistant epilepsy showed signs of clinically meaningful improvement, with some likely to achieve seizure freedom. • Findings highlight the need for larger, controlled clinical trials to establish efficacy, dosing, and safety of functional mushrooms as adjunctive epilepsy treatments.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.016
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Meta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.075
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0050.016
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.161
GPT teacher head0.453
Teacher spread0.292 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuePharmacological Research - Natural ProductsSame topicChemical synthesis and alkaloidsFrench-language works237,207